Therapy News and Research

RSS

Telemedicine use appears to help urban communities achieve blood pressure goals

Using a telemedicine system to engage people in underserved, urban communities to measure and report their blood pressure remotely-outside of the doctor's office-appears to help them achieve blood pressure goals and improve adherence to lifestyle changes and medication recommendations, according to research being presented at the American College of Cardiology's 62nd Annual Scientific Session.

8 Mar 2013

'Science Speaks' blog reports from 20th Conference on Retroviruses and Opportunistic Infections

The Center for Global Health Policy's "Science Speaks" blog on Wednesday published a series of posts on the 20th Conference on Retroviruses and Opportunistic Infections (CROI), which took place in Atlanta, Georgia, from Sunday to Wednesday.

8 Mar 2013

SCCA, ProCure announce opening of Seattle Cancer Care Alliance Proton Therapy

Seattle Cancer Care Alliance (SCCA) and ProCure Treatment Centers, Inc. (ProCure) announced the opening of Seattle Cancer Care Alliance Proton Therapy, A ProCure Center today in Seattle, Washington.

8 Mar 2013

Family-focused therapy improves mood symptoms in youth at risk of bipolar disorder

A study published in the February 2013 issue of the Journal of the American Academy of Child and Adolescent Psychiatry found that children and adolescents with major depression or subthreshold forms of bipolar disorder - and who had at least one first-degree relative with bipolar disorder - responded better to a 12-session family-focused treatment than to a briefer educational treatment.

8 Mar 2013

Minor weight loss may increase risk of cardiac events among patients implanted with CRT-D

Even minor weight loss is associated with worse health outcomes among patients implanted with a certain type of defibrillator known as cardiac resynchronization therapy with defibrillator (CRT-D), according to research being presented at the American College of Cardiology's 62nd Annual Scientific Session.

8 Mar 2013

Melittin-loaded nanoparticles can destroy human immunodeficiency virus

Nanoparticles carrying a toxin found in bee venom can destroy human immunodeficiency virus (HIV) while leaving surrounding cells unharmed, researchers at Washington University School of Medicine in St. Louis have shown.

8 Mar 2013

New Orleans residents continue to face increased risk of heart attack post-Katrina

New Orleans residents continue to face a three-fold increased risk of heart attack post-Katrina-a trend that has remained unchanged since the storm hit in 2005, according to research being presented at the American College of Cardiology's 62nd Annual Scientific Session.

7 Mar 2013

Acid reflux can kill certain cancer cells

A University of Central Florida chemist has come up with a unique way to kill certain cancer cells - give them acid reflux.

7 Mar 2013

Cochlear implants improve speech perception in early bilateral SNHL

Cochlear implant surgery in children with an early diagnosis of bilateral sensorineural hearing loss results in significant progressive improvements in speech perception and intelligibility, suggest study findings.

7 Mar 2013

Tranexamic acid role in coronary bypass surgery

Tranexamic acid balances the increased bleeding risk associated with recent clopidogrel use in patients undergoing on-pump coronary artery bypass grafting, shows a randomized trial.

7 Mar 2013

Taping improves ROM effects of Mulligan’s Mobilisation-with-Movement

Combining the Mulligan’s Mobilisation-with-Movement technique for the shoulder with taping provides a sustained improvement in range of movement for up to a week that is superior to that with Mobilisation-with-Movement alone, researchers report.

7 Mar 2013

Genomic analysis could illuminate more options in developing precise treatments for cancer

Investigators working on the precision medicine initiative at The Cancer Institute of New Jersey are embarking on a genomic analysis study which could illuminate more options in developing personalized and precise treatments for cancer patients.

7 Mar 2013

RA patients who initiate anti-TNF therapies do not have higher risk of shingles: Study

Although patients with rheumatoid arthritis have a disproportionately higher incidence of herpes zoster (shingles), an analysis that included nearly 60,000 patients with RA and other inflammatory diseases found that those who initiated anti-tumor necrosis factor therapies were not at higher risk of herpes zoster compared with patients who initiated nonbiologic treatment regimens, according to a study appearing in the March 6 issue of JAMA.

7 Mar 2013

Carbamylation contributes to heart disease risk among patients with CKD undergoing dialysis

Kidney failure affects 25 million individuals in the U.S. and many more throughout the world. Loss of kidney function means the majority of these patients must undergo dialysis treatments to remove excess fluids and waste products. Although dialysis therapy coupled with medication has improved the life expectancy for people with kidney failure, for unknown reasons, patients' risk of sudden heart failure and death remains 10 to 20 times greater than average.

7 Mar 2013

Study combines induced pluripotent stem cell technology and genetic correction to treat DMD

Researchers at the University of Minnesota's Lillehei Heart Institute have combined genetic repair with cellular reprogramming to generate stem cells capable of muscle regeneration in a mouse model for Duchenne Muscular Dystrophy (DMD).

7 Mar 2013

DBS helps anorexia patients achieve and maintain improvements in body weight, mood and anxiety

In a world first, a team of researchers at the Krembil Neuroscience Centre and the University Health Network have shown that Deep Brain Stimulation (DBS) in patients with chronic, severe and treatment-resistant Anorexia Nervosa (anorexia) helps some patients achieve and maintain improvements in body weight, mood, and anxiety.

6 Mar 2013

FDA accepts AMAG’s Feraheme sNDA for review

AMAG Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has accepted for review the company's supplemental new drug application (sNDA) for Feraheme (ferumoxytol) Injection for Intravenous (IV) use, which was submitted to the FDA in December 2012.

6 Mar 2013

Therapy News and Research

Telemedicine use appears to help urban communities achieve blood pressure goals

'Science Speaks' blog reports from 20th Conference on Retroviruses and Opportunistic Infections

SCCA, ProCure announce opening of Seattle Cancer Care Alliance Proton Therapy

Family-focused therapy improves mood symptoms in youth at risk of bipolar disorder

Minor weight loss may increase risk of cardiac events among patients implanted with CRT-D

Melittin-loaded nanoparticles can destroy human immunodeficiency virus

New Orleans residents continue to face increased risk of heart attack post-Katrina

Acid reflux can kill certain cancer cells

Cochlear implants improve speech perception in early bilateral SNHL

Tranexamic acid role in coronary bypass surgery

Taping improves ROM effects of Mulligan’s Mobilisation-with-Movement

Genomic analysis could illuminate more options in developing precise treatments for cancer

RA patients who initiate anti-TNF therapies do not have higher risk of shingles: Study

Carbamylation contributes to heart disease risk among patients with CKD undergoing dialysis

Study combines induced pluripotent stem cell technology and genetic correction to treat DMD

DBS helps anorexia patients achieve and maintain improvements in body weight, mood and anxiety

FDA accepts AMAG’s Feraheme sNDA for review

Zinc protoporphyrin a marker for iron deficiency in low-income children

Fewer malaria cases, more artesunate resistance on Thai border

Drug to relieve pain of feline osteoarthritis identified

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News